13F Filings History of INGALLS & SNYDER LLC

Latest 13F report
Q4 2025 - 13 Feb 2026
Value $
$2,713,067,000
Signature - Title
Christian C Park - Managing Officer
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by INGALLS & SNYDER LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. INGALLS & SNYDER LLC reported 448 stock holdings with total value $2,713,067,000 as of Q4 2025. Top holdings included CORT, GOOGL, AAPL, MSFT, and PAAS.

Notify me when INGALLS & SNYDER LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 448 $2,713,067,000 +$75,551,514 -$167,429,856 -$91,878,342 CORT, GOOGL, AAPL, MSFT, PAAS 13F-HR 13 Feb 2026, 10:11
Q3 2025 454 $3,045,524,000 +$70,856,303 -$72,166,704 -$1,310,401 CORT, MSFT, AAPL, WMB, BRKB 13F-HR 07 Nov 2025, 14:06
Q2 2025 445 $2,808,905,000 +$97,251,077 -$77,067,791 +$20,183,286 CORT, MSFT, WMB, BRKB, XOM 13F-HR 31 Jul 2025, 16:07
Q1 2025 435 $3,025,919,000 +$91,093,207 -$116,909,624 -$25,816,417 CORT, BRKB, XOM, AAPL, WMB 13F-HR 12 May 2025, 14:58
Q4 2024 428 $2,538,050,000 +$43,802,593 -$122,014,888 -$78,212,295 CORT, AAPL, MSFT, XOM, BRKB 13F-HR 29 Jan 2025, 16:38
Q3 2024 439 $2,548,989,000 +$89,456,632 -$56,162,192 +$33,294,440 CORT, XOM, AAPL, MSFT, CNQ 13F-HR 14 Nov 2024, 16:31
Q2 2024 414 $2,314,723,000 +$223,237,784 -$167,651,538 +$55,586,246 CORT, XOM, MSFT, CNQ, AAPL 13F-HR 31 Jul 2024, 11:51
Q1 2024 426 $2,252,361,000 +$69,714,993 -$125,824,894 -$56,109,901 CORT, CNQ, PXD, MSFT, BRKB 13F-HR 13 May 2024, 14:47
Q4 2023 424 $2,202,967,000 +$37,609,632 -$79,597,522 -$41,987,890 CORT, PXD, CNQ, AAPL, MSFT 13F-HR 29 Jan 2024, 16:19
Q3 2023 417 $2,066,739,000 +$78,833,235 -$70,612,779 +$8,220,456 CORT, PXD, CNQ, AAPL, MSFT 13F-HR 02 Nov 2023, 13:57
Q2 2023 415 $2,069,659,000 +$64,024,902 -$40,692,376 +$23,332,526 CORT, PXD, AAPL, CNQ, MSFT 13F-HR 27 Jul 2023, 10:03
Q1 2023 411 $1,936,158,000 +$82,209,501 -$31,305,807 +$50,903,694 CORT, PXD, CNQ, AAPL, MSFT 13F-HR 09 May 2023, 15:52
Q4 2022 418 $1,825,503,000 +$37,051,961 -$92,205,817 -$55,153,856 CORT, PXD, CNQ, BRKB, AAPL 13F-HR 31 Jan 2023, 16:44
Q3 2022 410 $1,777,231,000 +$85,373,040 -$56,486,515 +$28,886,525 CORT, PXD, CNQ, AAPL, BRKB 13F-HR 21 Oct 2022, 14:29
Q2 2022 422 $1,896,635,000 +$52,304,072 -$57,171,962 -$4,867,890 CORT, PXD, CNQ, AAPL, MSFT 13F-HR 11 Aug 2022, 10:35
Q1 2022 436 $2,217,865,000 +$64,268,471 -$109,110,108 -$44,841,637 CORT, PXD, CNQ, AAPL, MSFT 13F-HR 09 May 2022, 10:56
Q4 2021 443 $2,194,592,000 +$41,183,093 -$110,924,511 -$69,741,418 CORT, PXD, AAPL, MSFT, CNQ 13F-HR 11 Feb 2022, 16:24
Q3 2021 433 $2,160,389,000 +$58,311,213 -$81,086,007 -$22,774,794 CORT, PXD, AAPL, MSFT, CNQ 13F-HR 27 Oct 2021, 13:26
Q2 2021 434 $2,226,541,000 +$75,433,043 -$70,803,362 +$4,629,681 CORT, PXD, AAPL, MSFT, CNQ 13F-HR 03 Aug 2021, 13:45
Q1 2021 418 $2,124,728,000 +$72,150,024 -$92,499,050 -$20,349,026 CORT, PXD, OMER, AAPL, MSFT 13F-HR 21 Apr 2021, 13:45
Q4 2020 409 $2,011,033,000 +$378,793,475 -$94,150,863 +$284,642,612 CORT, AAPL, PXD, MSFT, OMER 13F-HR 27 Jan 2021, 15:36
Q3 2020 356 $1,448,182,000 +$41,479,335 -$344,068,753 -$302,589,418 CORT, MSFT, PXD, OMER, PG 13F-HR 21 Oct 2020, 13:08
Q2 2020 388 $1,729,614,000 +$42,717,557 -$129,869,463 -$87,151,906 CORT, AAPL, PXD, OMER, MSFT 13F-HR 31 Jul 2020, 11:24
Q1 2020 391 $1,472,038,000 +$246,828,656 -$78,150,404 +$168,678,252 CORT, OMER, AAPL, MSFT, PXD 13F-HR 22 Apr 2020, 15:30
Q4 2019 384 $1,826,798,000 +$64,280,577 -$352,218,946 -$287,938,369 PXD, CORT, OMER, CNQ, MSFT 13F-HR 15 Jan 2020, 10:47
Q3 2019 410 $2,029,740,000 +$68,018,808 -$94,182,168 -$26,163,360 CORT, PXD, OMER, AAPL, BRKB 13F-HR 16 Oct 2019, 09:23
Q2 2019 409 $2,067,832,000 +$99,873,510 -$163,223,707 -$63,350,197 PXD, CORT, OMER, BRKB, AAPL 13F-HR 11 Jul 2019, 15:33
Q1 2019 401 $2,091,699,000 +$49,784,181 -$84,889,654 -$35,105,473 PXD, CORT, OMER, HXL, CNQ 13F-HR 11 Apr 2019, 14:53
Q4 2018 397 $1,887,968,000 +$51,169,819 -$108,779,634 -$57,609,815 PXD, CORT, HXL, BRKB, OMER 13F-HR 24 Jan 2019, 08:46
Q3 2018 432 $2,362,847,000 +$216,514,906 -$68,234,226 +$148,280,680 PXD, OMER, CORT, HXL, CNQ 13F-HR 24 Oct 2018, 10:02
Q2 2018 398 $2,146,213,000 +$75,327,837 -$66,922,349 +$8,405,488 PXD, CORT, OMER, CNQ, HXL 13F-HR 10 Aug 2018, 17:02
Q1 2018 395 $2,043,330,000 +$90,126,747 -$98,370,708 -$8,243,961 PXD, CORT, HXL, OMER, CNQ 13F-HR 17 Apr 2018, 12:11
Q4 2017 392 $2,163,557,000 +$264,669,840 -$92,784,832 +$171,885,008 PXD, CORT, OMER, HXL, WMB 13F-HR 19 Jan 2018, 10:36
Q3 2017 358 $1,909,308,000 +$90,465,517 -$125,341,162 -$34,875,645 PXD, CORT, OMER, HXL, WMB 13F-HR 20 Oct 2017, 14:50
Q2 2017 356 $1,825,036,000 +$108,409,186 -$168,346,543 -$59,937,357 PXD, OMER, CORT, HXL, WMB 13F-HR 28 Jul 2017, 09:27
Q1 2017 397 $1,863,062,000 +$76,072,407 -$125,589,814 -$49,517,407 PXD, CORT, OMER, HXL, WMB 13F-HR 09 May 2017, 10:34
Q4 2016 394 $1,816,188,000 +$58,972,963 -$71,388,861 -$12,415,898 PXD, HXL, WMB, CORT, OMER 13F-HR 25 Jan 2017, 16:49
Q3 2016 399 $1,772,925,000 +$65,325,773 -$101,250,994 -$35,925,221 PXD, HXL, WMB, OMER, CORT 13F-HR 03 Nov 2016, 11:23
Q2 2016 409 $1,694,786,000 +$1,694,786,000 -$1,572,689 +$1,693,213,311 PXD, HXL, CORT, WMB, OMER 13F-HR 11 Aug 2016, 14:59
Q1 2016 366 $1,572,689 +$55,410 -$74,550 -$19,140 PIONEER NATURAL RESOURCES CO, HEXCEL CORP, OMEROS CORP, CORCEPT THERAPEUTICS INC, WILLIAMS COMPANIES, INC 13F-HR 29 Apr 2016, 13:47
Q4 2015 377 $1,565,194 +$61,600 -$83,013 -$21,413 PIONEER NATURAL RESOURCES CO, HEXCEL CORP, WILLIAMS COMPANIES, INC, OMEROS CORP, CORCEPT THERAPEUTICS INC 13F-HR 27 Jan 2016, 08:34
Q3 2015 363 $1,529,657 +$55,098 -$67,311 -$12,213 PIONEER NATURAL RESOURCES CO, HEXCEL CORP, WILLIAMS COMPANIES, INC, OMEROS CORP, GENERAL ELECTRIC COMPANY 13F-HR 27 Oct 2015, 10:33
Q2 2015 377 $1,812,598 +$72,270 -$41,955 +$30,315 PIONEER NATURAL RESOURCES CO, WILLIAMS COMPANIES, INC, HEXCEL CORP, OMEROS CORP, CORCEPT THERAPEUTICS INC 13F-HR 10 Jul 2015, 12:44
Q1 2015 380 $1,815,875 +$98,762 -$66,954 +$31,808 PIONEER NATURAL RESOURCES CO, WILLIAMS COMPANIES, INC, HEXCEL CORP, OMEROS CORP, CORCEPT THERAPEUTICS INC 13F-HR 15 Apr 2015, 13:40
Q4 2014 374 $1,724,282 +$95,680 -$182,017 -$86,337 PIONEER NATURAL RESOURCES CO, WILLIAMS COMPANIES, INC, HEXCEL CORP, OMEROS CORP, BERKSHIRE HATHAWAY INC CL B 13F-HR 28 Jan 2015, 10:26
Q3 2014 378 $1,858,757 +$62,082 -$186,509 -$124,427 PIONEER NATURAL RESOURCES CO, WILLIAMS COMPANIES, INC, HEXCEL CORP, BERKSHIRE HATHAWAY INC CL B, DEPOMED INC 13F-HR 28 Oct 2014, 15:34
Q2 2014 382 $2,034,674 +$104,710 -$45,443 +$59,267 PIONEER NATURAL RESOURCES CO, WILLIAMS COMPANIES, INC, HEXCEL CORP, AVANIR PHARMACEUTICALS INC, DEPOMED INC 13F-HR 30 Jul 2014, 11:12
Q1 2014 369 $1,865,854 +$115,782 -$109,461 +$6,321 PIONEER NATURAL RESOURCES CO, WILLIAMS COMPANIES, INC, HEXCEL CORP, DEPOMED INC, AVANIR PHARMACEUTICALS INC 13F-HR 02 May 2014, 11:24
Q4 2013 351 $1,814,481 $0 $0 $0 PIONEER NATURAL RESOURCES CO, HEXCEL CORP, WILLIAMS COMPANIES, INC, DEPOMED INC, EXXON MOBIL CORP. 13F-HR 24 Jan 2014, 12:27